closed system kit

MIAMI, Sept.8, 2016—Adimarket, a subsidiary of Global Stem Cells Group, Inc., has announced that Korean biotech leader N-Biotek is developing a new closed system kit containing all of the elements necessary to process adipose tissue and obtain stromal vascular fraction (SVF) in a closed environment. Created with N-Biotek technology, the system will allow entire procedures

Benito Novas

Benito Novas, founder, CEO and creative director of Global Stem Cells Group. Mr.Novas spearheaded and launched Stem Cell Training Inc. to provide professional training courses in stem cell therapies for physicians. Mr. Novas oversees Stem Cell Training’s marketing programs, finance strategies, field operations administration, policies, procedures and accreditation. Prior to founding The Global Stem Cells

stem cell training korea

MIAMI, Aug. 30, 2016 – Global Stem Cells Group and its subsidiary Stem Cell Training, Inc., in a collaborative agreement with South Korean biomedical company N-Biotek, announce the establishment of a permanent stem cell training center at the N-Biotek headquarters in Seoul, South Korea. The announcement comes as part of an ambitious expansion effort between

Buenos Airies stem cell symposium

Buenos Aires stem cell symposium scheduled for Sept. 28, 2016. MIAMI, Aug. 30, 2016 – Global Stem Cells Group, in conjunction with Julio Ferreira, M.D., President of the South American Academy Cosmetic Surgery, will host the 3rd annual Global Stem Cells Group International Symposium on Stem Cells and Regenerative Medicine Sept. 28, 2016. The event,

Silvina Pastrana, M.D.

Monday, 29 August 2016 by
Sylvina Pastrana, M.D.

Silvina Pastrana, M.D. is medical director of the Stem Cell Center Buenos Aires and Regentherapy Puerto Madero. Dr. Pastrana heads a staff of medical specialists in orthopedics, rheumatology, medical clinic and cosmetic surgery, performing procedures that incorporate stem cell therapies. Dr. Pastrana also serves as a staff surgeon for the Hospital Dr. Prof. Luis Güemes.

Monday, 29 August 2016 by

Enrique Testart, M.D.

Monday, 29 August 2016 by
Enrique Testart, M.D.

Enrique Testart, M.D., Global Stem Cells Group’s Chief Medical Officer (CMO), is a surgeon specializing in child trauma microsurgery. Dr. Testart is also a medical entrepreneur and founder of Consortia Innovas S.A. in Santiago, Chile, dedicated to consulting and clinical health management for clinical management firms and research and development-oriented planners in the latest treatments

stem cell medicine

Stem cell medicine is based on the concept that physicians can harness the body’s own reserves to heal itself, rather than relying exclusively on drugs or invasive surgical procedures. Stem cell medicine works by deals engineering human stem cells to replace or restore damaged or diseased organs or tissue, or establish normal function in them. While

adipose stem cell therapies

Adipose stem cells (pictured) harvested from body fat. (Photo: Genetic Engineering & Biotechnology News). The discovery of abundant stem cell populations in body fat tissue changed everything the medical community thought it knew about stem cells overnight. Now, adipose stem cell therapies are driving the plastic and cosmetic surgery industries, and demand among patients keeps

Thursday, 25 August 2016 by